Welcome to our dedicated page for Delek US Holdings SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Delek US Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Delek US Holdings's regulatory disclosures and financial reporting.
DK filing a Section 144 notice indicating 5,000 common shares are to be sold. The filing lists the broker Morgan Stanley Smith Barney LLC and identifies the securities as restricted stock units dated 03/10/2019.
It also discloses a recent sale of 5,392 shares on 03/04/2026 for $230,508.00.
Delek US Holdings EVP Denise Clark McWatters reported an open-market sale of 11,988 shares of common stock at $41.33 per share. After this transaction, she directly holds 74,196 shares of Delek US Holdings common stock, indicating she retains a substantial ongoing equity stake in the company.
DK submitted a Form 144 notice disclosing planned sales of restricted common stock that vested on multiple dates in 2022–2024. The notice lists broker Fidelity Brokerage Services LLC and vesting line items including 06/10/2022 (489 shares) and 09/10/2022 (1,935 shares).
Delek US Holdings EVP Robert G. Wright reported routine equity compensation activity. On March 10, 2026, he acquired 12,934 shares of common stock at no cost upon vesting of performance-based restricted stock units and received a separate grant of 3,075 time-vesting restricted stock units that vest over three years.
On the same date, 9,562 shares were withheld at a price of $40.64 per share to cover tax obligations related to these equity awards, rather than being sold on the open market. After these transactions, Wright directly owned 58,868 shares of Delek US Holdings common stock.
Spiegel Reuven reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings EVP, Special Projects Reuven Spiegel received a grant of 9,842 shares of common stock as a time-vesting restricted stock unit award that vests over three years. After this compensation-related grant, his direct holdings increased to 58,372 common shares.
Delek US Holdings director Zohar Shlomo sold 5,000 shares of common stock in an open-market transaction at a price of $41.465 per share.
After this sale, Shlomo directly holds 13,989 shares of Delek US Holdings common stock, according to the latest ownership figures reported.
Delek US Holdings President & CEO Avigal Soreq reported multiple equity award transactions in common stock. On March 9 and 10, 2026, he acquired 95,249 shares through grants and vesting of restricted stock units, including performance-based awards and a new grant that vests over three years.
Across the same dates, 31,631 shares were disposed of at prices of $40.13 and $40.64 per share to cover tax obligations upon vesting of equity awards. After these transactions, Soreq directly holds 315,296 shares of Delek US Holdings common stock, indicating these are routine compensation-related grants and tax withholdings rather than open-market trades.
Delek US Holdings EVP and General Counsel Denise Clark McWatters reported routine equity compensation activity in company stock. On March 9 and 10, she received grants totaling 13,513 shares of common stock at no cost upon vesting of performance-based restricted stock units. In connection with these vestings, 11,606 shares were automatically withheld to cover tax obligations at prices of $40.13 and $40.64 per share, rather than sold on the open market. After these transactions, she directly holds 86,184 shares of Delek US Holdings common stock.
Delek US Holdings EVP and CFO Mark Wayne Hobbs reported stock-based compensation activity involving the company’s common stock. On March 9–10, he acquired multiple share awards at no cash cost to him, including grants tied to the vesting of performance-based and time-vesting restricted stock units.
The filing also shows 6,388 shares were disposed of through share withholding to cover tax obligations upon vesting, rather than through open-market sales. After these transactions, Hobbs directly holds 125,149 shares of Delek US Holdings common stock.
Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock. On March 6, he received 4,301 shares as a grant or award, tied to the vesting of performance-based restricted stock units. That same day, 1,693 shares were withheld at $42.29 per share to cover tax obligations on the vesting.
On March 9, an additional 353 shares were withheld at $40.13 per share for tax purposes. After these transactions, Joseph directly held 57,878 shares of Delek US common stock. The dispositions reflect tax-withholding mechanics rather than open-market sales.